Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ltd V.AVE


Primary Symbol: AVEFF

Healthcare
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Avecho Biotechnology Ltd
Bullboard Posts
User Avatar Image
(0)
•••
Post by 93Darkhorse93on Aug 09, 2017 4:59pm
144 Views
Post# 26563168

May 2017 Investor Presentation - BV really 1.02/Share...

May 2017 Investor Presentation - BV really 1.02/Share...Love your conviction Muskoka. Your closing remark made me laugh, I would just add on to your point with a little more depth using the latest investor presentation: (https://www.avedaenergy.com/investor-hub/presentations/PresentationDetails/2017/Investor-Presentation---May-2017/default.aspx) SEE PAGE 10- FMV of equipment is actually 115.1M but yet on the books for 96.5M. That adds close to another 20M to your true BV calculation bringing the number closer to 1.00/share. SEE PAGE 15- April 2017 revenue of 16.8M up from 1.5M YoY or 1,020% revenue growth!!!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities